Clinical characteristics and outcome of intracerebral hemorrhage in young adults. 2014

Loes Ca Rutten-Jacobs, and Noortje Am Maaijwee, and Renate M Arntz, and Hennie C Schoonderwaldt, and Lucille D Dorresteijn, and Ewoud J van Dijk, and Frank-Erik de Leeuw
Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands, lr406@medschl.cam.ac.uk.

Data on determinants of prognosis after intracerebral hemorrhage (ICH) in young adults are scarce. Our aim was to identify clinical determinants of prognosis after ICH in adults aged 18-50. We investigated 98 consecutive patients with an ICH, aged 18-50 years, admitted to our hospital between 1980 and 2010. Collected ICH characteristics included presenting symptoms, etiology, location, severity and Glasgow Coma Scale (GCS). Outcomes were case-fatality (death within 30 days), poor functional outcome (modified Rankin Scale >2), long-term mortality and recurrent ICH. We assessed discriminatory power of factors associated with case-fatality [area under receiver operating curve (AUC)]. Case-fatality was 20.4 % (n = 20) and well predicted by the GCS (AUC 0.83). Among 30-day survivors, a poor functional outcome at discharge was present in 51.3 %. During a mean follow-up of 11.3 years mortality was only increased in patients aged 40-50 years [standardized mortality ratio 4.8 (95 % CI 2.3-8.6)], but not in patients aged 18-40 years. Recurrent ICH occurred in 6 patients [10-year cumulative incidence 12.2 % (95 % CI 1.5-22.9 %)], all with the index ICH attributable to structural vascular malformations. Prognosis after ICH in young adults is poor, mainly due to high case-fatality, that is well predicted by the GCS. An exception is 30-day survivors <40 years, who have a similar risk of dying as the general population. Recurrence risk is especially present in patients with structural vascular malformations, whereas risk seems to be very low in other patients.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002543 Cerebral Hemorrhage Bleeding into one or both CEREBRAL HEMISPHERES including the BASAL GANGLIA and the CEREBRAL CORTEX. It is often associated with HYPERTENSION and CRANIOCEREBRAL TRAUMA. Brain Hemorrhage, Cerebral,Cerebral Parenchymal Hemorrhage,Hemorrhage, Cerebral,Intracerebral Hemorrhage,Hemorrhage, Cerebrum,Brain Hemorrhages, Cerebral,Cerebral Brain Hemorrhage,Cerebral Brain Hemorrhages,Cerebral Hemorrhages,Cerebral Parenchymal Hemorrhages,Cerebrum Hemorrhage,Cerebrum Hemorrhages,Hemorrhage, Cerebral Brain,Hemorrhage, Cerebral Parenchymal,Hemorrhage, Intracerebral,Hemorrhages, Cerebral,Hemorrhages, Cerebral Brain,Hemorrhages, Cerebral Parenchymal,Hemorrhages, Cerebrum,Hemorrhages, Intracerebral,Intracerebral Hemorrhages,Parenchymal Hemorrhage, Cerebral,Parenchymal Hemorrhages, Cerebral
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015600 Glasgow Coma Scale A scale that assesses the response to stimuli in patients with craniocerebral injuries. The parameters are eye opening, motor response, and verbal response. Coma Scale, Glasgow,Scale, Glasgow Coma
D015996 Survival Rate The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. Cumulative Survival Rate,Mean Survival Time,Cumulative Survival Rates,Mean Survival Times,Rate, Cumulative Survival,Rate, Survival,Rates, Cumulative Survival,Rates, Survival,Survival Rate, Cumulative,Survival Rates,Survival Rates, Cumulative,Survival Time, Mean,Survival Times, Mean,Time, Mean Survival,Times, Mean Survival
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

Loes Ca Rutten-Jacobs, and Noortje Am Maaijwee, and Renate M Arntz, and Hennie C Schoonderwaldt, and Lucille D Dorresteijn, and Ewoud J van Dijk, and Frank-Erik de Leeuw
November 1989, Annals of emergency medicine,
Loes Ca Rutten-Jacobs, and Noortje Am Maaijwee, and Renate M Arntz, and Hennie C Schoonderwaldt, and Lucille D Dorresteijn, and Ewoud J van Dijk, and Frank-Erik de Leeuw
May 1987, Archives of neurology,
Loes Ca Rutten-Jacobs, and Noortje Am Maaijwee, and Renate M Arntz, and Hennie C Schoonderwaldt, and Lucille D Dorresteijn, and Ewoud J van Dijk, and Frank-Erik de Leeuw
April 2005, European journal of neurology,
Loes Ca Rutten-Jacobs, and Noortje Am Maaijwee, and Renate M Arntz, and Hennie C Schoonderwaldt, and Lucille D Dorresteijn, and Ewoud J van Dijk, and Frank-Erik de Leeuw
January 2021, Acta neurologica Scandinavica,
Loes Ca Rutten-Jacobs, and Noortje Am Maaijwee, and Renate M Arntz, and Hennie C Schoonderwaldt, and Lucille D Dorresteijn, and Ewoud J van Dijk, and Frank-Erik de Leeuw
October 2020, Scientific reports,
Loes Ca Rutten-Jacobs, and Noortje Am Maaijwee, and Renate M Arntz, and Hennie C Schoonderwaldt, and Lucille D Dorresteijn, and Ewoud J van Dijk, and Frank-Erik de Leeuw
December 2016, Journal of neurosurgery,
Loes Ca Rutten-Jacobs, and Noortje Am Maaijwee, and Renate M Arntz, and Hennie C Schoonderwaldt, and Lucille D Dorresteijn, and Ewoud J van Dijk, and Frank-Erik de Leeuw
December 2012, Clinical neurology and neurosurgery,
Loes Ca Rutten-Jacobs, and Noortje Am Maaijwee, and Renate M Arntz, and Hennie C Schoonderwaldt, and Lucille D Dorresteijn, and Ewoud J van Dijk, and Frank-Erik de Leeuw
September 2013, Journal of cerebrovascular and endovascular neurosurgery,
Loes Ca Rutten-Jacobs, and Noortje Am Maaijwee, and Renate M Arntz, and Hennie C Schoonderwaldt, and Lucille D Dorresteijn, and Ewoud J van Dijk, and Frank-Erik de Leeuw
January 2015, Stroke research and treatment,
Loes Ca Rutten-Jacobs, and Noortje Am Maaijwee, and Renate M Arntz, and Hennie C Schoonderwaldt, and Lucille D Dorresteijn, and Ewoud J van Dijk, and Frank-Erik de Leeuw
April 2024, Neurocritical care,
Copied contents to your clipboard!